Examining the consequences of discontinuing GLP-1 medications on addiction-related hospitalizations

GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Originally developed to treat type 2 diabetes, they are now also used to treat severe obesity. In recent years, studies have provided evidence that they may also reduce the consumption of alcohol and other substances. However, it has not been clear whether these potential effects persist after the medication is discontinued.

Raccontata daforbes.commedicalxpress.comindependent.co.uk